Ingredion (INGR) Q2 2026: Beat on Both Lines Despite Argo Plant Hit
As seen on the 24/7 Wall St. homepage on August 4, 2026.
Ingredion beat on both lines even with the Argo plant fallout cutting U.S./Canada segment operating income by 33%, and management held full-year adjusted EPS guidance. Texture and Healthful Solutions logged another quarter of volume growth on clean-label demand. Next catalyst: closing the all-cash Tate and Lyle deal, now approved by its shareholders.
Continue ReadingShow less
Ingredion reported Q2 2026 adjusted EPS of $2.82, clearing the $2.72 consensus estimate by about 3.6%. Revenue came in at $1.85 billion, topping expectations of roughly $1.83 billion. The results arrived even as fallout from the Argo plant disruption dragged U.S. and Canada segment operating income down 33%, a meaningful headwind that the company managed to absorb at the overall earnings level.
The Texture and Healthful Solutions segment continued to be a bright spot, posting another quarter of volume growth driven by persistent clean-label demand from food and beverage customers. Management chose to hold its full-year adjusted EPS guidance unchanged, signaling confidence that the Argo impact is containable and that the rest of the portfolio can carry the load through the back half of the year.
Sponsored
Don't wait: the analyst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
The next major event for investors to watch is the closing of Ingredion's all-cash acquisition of Tate and Lyle, which has now cleared the shareholder approval hurdle. That deal, once completed, stands to reshape the company's specialty ingredients footprint considerably. The EPS beat also extends a mostly solid stretch for the company — seven of the last nine quarters have seen Ingredion come in above the Wall Street estimate.
Mentioned: INGR